Cargando…

Editorial: RNAs at the crossroads between effectors and targets; discovery and development of new drugs

Detalles Bibliográficos
Autores principales:	Chiappori, Federica, Mollica, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010567/ https://www.ncbi.nlm.nih.gov/pubmed/36923644 http://dx.doi.org/10.3389/fmolb.2023.1157440

Ejemplares similares

An overview of structural approaches to study therapeutic RNAs
por: Mollica, Luca, et al.
Publicado: (2022)

Targeting the Essential Transcription Factor HP1043 of Helicobacter pylori: A Drug Repositioning Study
por: Antoniciello, Federico, et al.
Publicado: (2022)

Editorial: Antiviral drug discovery against pathogens of pandemic concern: Advancements in target site identification and structure-based drug development
por: Padmanabha Das, Krishna M.
Publicado: (2023)

Editorial: “Small molecules targeting transmembrane receptors and ion channels in drug discovery”
por: Vitale, Rosa Maria, et al.
Publicado: (2023)

Editorial: Molecular Dynamics and Machine Learning in Drug Discovery
por: Decherchi, Sergio, et al.
Publicado: (2021)

Editorial: Integration of structural biology data in lead drug discovery and optimization
por: Roversi, Pietro, et al.
Publicado: (2023)

Allosteric Regulation at the Crossroads of New Technologies: Multiscale Modeling, Networks, and Machine Learning
por: Verkhivker, Gennady M., et al.
Publicado: (2020)

Editorial: Drug discovery from natural sources: Animal venoms, plants, bacteria and fungi
por: Kwok, Hang Fai
Publicado: (2022)

Application of Fragment-Based Drug Discovery to Versatile Targets
por: Li, Qingxin
Publicado: (2020)

Targeting the ubiquitin system by fragment-based drug discovery
por: Kennedy, Cassandra, et al.
Publicado: (2022)

Editorial: Analytical devices based on immobilized macromolecules for structural and activity/affinity studies in drug discovery
por: Temporini, Caterina, et al.
Publicado: (2022)

Recent Developments in Free Energy Calculations for Drug Discovery
por: King, Edward, et al.
Publicado: (2021)

Editorial: Tumorigenesis Regulated by miRNAs
por: Ye, Wei, et al.
Publicado: (2022)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms
por: Ye, Yanting, et al.
Publicado: (2022)

Editorial: Structural and Functional Characterization of Circular RNAs
por: Grammatikakis, Ioannis, et al.
Publicado: (2021)

Editorial: Small non-coding RNAs in diseases
por: Zhang, Ke, et al.
Publicado: (2023)

Editorial: Applications of metabolomics to the discovery of biomolecules from natural products
por: Choi, Young Hae, et al.
Publicado: (2023)

Editorial: Leveraging machine learning for omics-driven biomarker discovery
por: Li, Sheng, et al.
Publicado: (2023)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms, Volume II
por: Jerez, Sofia, et al.
Publicado: (2023)

Editorial: Small RNAs as a Diverse Toolkit for Bacteria
por: Ozoline, Olga, et al.
Publicado: (2021)

Editorial: Tumorigenesis regulated by miRNAs, Volume II
por: Liu, Taomei, et al.
Publicado: (2023)

Fragment-Based Drug Discovery by NMR. Where Are the Successes and Where can It Be Improved?
por: Mureddu, Luca G., et al.
Publicado: (2022)

Editorial: Venom Peptides: A Rich Combinatorial Library for Drug Development
por: Cardoso, Fernanda C., et al.
Publicado: (2022)

Editorial: The role of MicroRNAs and other non-coding RNAs in gut inflammation and gastrointestinal cancers
por: Anbazhagan, Arivarasu N., et al.
Publicado: (2023)

Editorial: Volume II: Structural and functional characterization of circular RNAs
por: Sinha, Tanvi, et al.
Publicado: (2022)

Editorial: Exploring circular RNAs and their applications within health and disease
por: Becatti, Matteo, et al.
Publicado: (2023)

Editorial: Peptides Targeting Protein-Protein Interactions: Methods and Applications
por: Belvisi, Laura, et al.
Publicado: (2021)

Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
por: Arif, Sheikh Mohammed, et al.
Publicado: (2022)

Editorial: New Strategies for the Diagnosis and Treatment of Multi-Drug Resistant Bacteria or Fungi in Wounds
por: Chin, Kok-Yong
Publicado: (2023)

Drug discovery by a basic research scientist
por: Eaton, William A.
Publicado: (2022)

Editorial: Venom peptides: A rich combinatorial library for drug development, volume II
por: Servent, Denis, et al.
Publicado: (2023)

Bio-Layer Interferometry Analysis of the Target Binding Activity of CRISPR-Cas Effector Complexes
por: Müller-Esparza, Hanna, et al.
Publicado: (2020)

Editorial: Interactions Between Small Molecule Ligands and Target Enzymes
por: Kim, Sung-Kun, et al.
Publicado: (2021)

Editorial: The Role of Epithelial-Mesenchymal Transition-Related Non-Coding RNAs in Cancer
por: Cao, Rui, et al.
Publicado: (2022)

Current Strategies of Antiviral Drug Discovery for COVID-19
por: Mei, Miao, et al.
Publicado: (2021)

Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
por: Laeremans, Toon, et al.
Publicado: (2022)

Hedgehog Autoprocessing: From Structural Mechanisms to Drug Discovery
por: Kandel, Nabin, et al.
Publicado: (2022)

Recent applications of computational methods to allosteric drug discovery
por: Govindaraj, Rajiv Gandhi, et al.
Publicado: (2023)

Editorial: Primary cilia as therapeutic targets
por: Nishimura, Yuhei, et al.
Publicado: (2023)

Editorial: Pharmacometabolomics: biomarker discovery, precision medicine, technical advances, perspectives and future applications in respiratory diseases
por: Vignoli, Alessia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_87kaqi74ku8fgl5802ushsdq24